Relief Therapeutics Holding AG
RLFTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $53 | $22 | $114 | $212 |
| - Cash | $15 | $15 | $19 | $45 |
| + Debt | $2 | $3 | $3 | $3 |
| Enterprise Value | $40 | $10 | $98 | $171 |
| Revenue | $8 | $6 | $6 | $3 |
| % Growth | 39.5% | -0.8% | 83.1% | – |
| Gross Profit | $6 | $4 | $5 | $3 |
| % Margin | 69.4% | 71.2% | 79.4% | 77.4% |
| EBITDA | -$17 | -$108 | -$49 | -$33 |
| % Margin | -197% | -1,790.8% | -806.2% | -984.4% |
| Net Income | -$17 | -$98 | -$51 | -$35 |
| % Margin | -203.4% | -1,627.4% | -835.2% | -1,045% |
| EPS Diluted | -1.37 | -8.35 | -4.8 | -3.86 |
| % Growth | 83.6% | -74% | -24.4% | – |
| Operating Cash Flow | -$3 | -$18 | -$24 | -$36 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$14 |
| Free Cash Flow | -$3 | -$18 | -$25 | -$49 |